BLACK DIAMOND THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $2.79 million as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-16
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.79M.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.87M.
- 2024-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4.16M.
- 2024-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4.47M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $2.79M 10-K · filed 2026-03-16 |
| 2024-12-31 | $3.87M 10-K · filed 2025-03-06 |
| 2024-09-30 | $4.16M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $4.47M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $4.78M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $5.11M 10-K · filed 2024-03-12 |
| 2023-09-30 | $5.45M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $5.79M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $6.15M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $6.51M 10-K · filed 2023-03-09 |
| 2022-09-30 | $6.89M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.27M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $7.65M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $8.03M 10-K · filed 2022-03-17 |
| 2021-09-30 | $8.42M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $3.04M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $3.24M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $1.88M 10-K · filed 2021-03-25 |
| 2020-09-30 | $1.89M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $29.00K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $38.00K 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |